موافقات الدواء

Thiotepa is indicated, in combination with other chemotherapy medicinal products:
• With or without total body irradiation (TBI), as conditioning treatment prior to allogeneic orautologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients.
• When high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.